Literature DB >> 10606978

Endogenous glucocorticoids modulate experimental anti-glomerular basement membrane glomerulonephritis.

M Leech1, X R Huang, E F Morand, S R Holdsworth.   

Abstract

The influence of endogenous glucocorticoids (GC) on glomerular injury was studied in a rat model of heterologous anti-glomerular basement membrane (GBM) glomerulonephritis (GN). Sprague-Dawley rats underwent adrenalectomy (ADX) or sham-operation 3 days prior to i.v. administration of both nephritogenic (100 microgram/g) and subnephritogenic (50 microgram/g) doses of sheep anti-rat GBM globulin. Administration of a subnephritogenic dose of anti-GBM globulin resulted in GN in adrenalectomized animals only. Similarly, ADX performed prior to administration of anti-GBM in the nephritogenic dose range resulted in exacerbation of GN compared with sham-operated animals (24 h protein excretion: 190.8 +/- 32.8 versus 42.5 +/- 2.6 mg/24 h; P < 0.005). In ADX animals receiving subnephritogenic doses of anti-GBM injury was manifested by abnormal proteinuria (62.7 +/- 5.8 mg/24 h), accumulation of neutrophils which peaked at 6 h (7.2 +/- 1.37 neutrophils per glomerular cross-section (neut/gcs)) and macrophage accumulation in glomeruli at 24 h (6.8 +/- 1.2 macrophages/gcs). Sham-adrenalectomized animals given the same dose of anti-GBM globulin developed minimal or no glomerular injury: urinary protein excretion (8.7 +/- 1.5 mg/24 h, P < 0.001); neutrophils (0.2 +/- 0.04 neutrophils/gcs, P < 0.001); macrophages (1.2 +/- 0.5 macrophages/gcs, P < 0.001). The increased cellular recruitment to glomeruli in adrenalectomized animals was associated with glomerular endothelial P-selectin expression. P-selectin expression was not detected in sham-operated rats after anti-GBM injection. Complement deposition in glomeruli was minimal in both groups. Physiologic GC replacement of ADX rats receiving subnephritogenic-dose anti-GBM reversed the observed susceptibility to GN development, with urinary protein excretion (7.8 +/- 1.12, P < 0.005) and no detectable P-selectin expression or leucocyte accumulation in glomeruli. These results suggest that endogenous GC modulate heterologous anti-GBM nephritis in rats and that this may be attributable, in part, to regulation of P-selectin expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10606978      PMCID: PMC1905532          DOI: 10.1046/j.1365-2249.2000.01086.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface.

Authors:  R Hattori; K K Hamilton; R P McEver; P J Sims
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

2.  PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells.

Authors:  R Bonfanti; B C Furie; B Furie; D D Wagner
Journal:  Blood       Date:  1989-04       Impact factor: 22.113

3.  Evidence for anti-inflammatory effect of normal circulating plasma cortisol.

Authors:  C Saldanha; G Tougas; E Grace
Journal:  Clin Exp Rheumatol       Date:  1986 Oct-Dec       Impact factor: 4.473

4.  Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140.

Authors:  R Hattori; K K Hamilton; R D Fugate; R P McEver; P J Sims
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

5.  GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies.

Authors:  R P McEver; J H Beckstead; K L Moore; L Marshall-Carlson; D F Bainton
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats.

Authors:  E M Sternberg; J M Hill; G P Chrousos; T Kamilaris; S J Listwak; P W Gold; R L Wilder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

7.  Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist.

Authors:  L Laue; S Kawai; D D Brandon; D Brightwell; K Barnes; R A Knazek; D L Loriaux; G P Chrousos
Journal:  J Steroid Biochem       Date:  1988-06       Impact factor: 4.292

8.  A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation.

Authors:  P E Stenberg; R P McEver; M A Shuman; Y V Jacques; D F Bainton
Journal:  J Cell Biol       Date:  1985-09       Impact factor: 10.539

9.  Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor.

Authors:  R Bertini; M Bianchi; P Ghezzi
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

10.  A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS.

Authors:  C G COCHRANE; E R UNANUE; F J DIXON
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

View more
  3 in total

1.  Endogenous glucocorticoids control neutrophil mobilization from bone marrow to blood and tissues in non-inflammatory conditions.

Authors:  D M H Cavalcanti; C M C Lotufo; P Borelli; Z S Ferreira; R P Markus; S H P Farsky
Journal:  Br J Pharmacol       Date:  2007-11-05       Impact factor: 8.739

2.  Independent roles of macrophage migration inhibitory factor and endogenous, but not exogenous glucocorticoids in regulating leukocyte trafficking.

Authors:  Julia L Gregory; Pam Hall; Michelle Leech; Eric F Morand; Michael J Hickey
Journal:  Microcirculation       Date:  2009-11       Impact factor: 2.628

3.  Myrcene Attenuates Renal Inflammation and Oxidative Stress in the Adrenalectomized Rat Model.

Authors:  Azim Ullah Shamsul Islam; Björn Hellman; Fred Nyberg; Naheed Amir; Richard L Jayaraj; Georg Petroianu; Abdu Adem
Journal:  Molecules       Date:  2020-09-30       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.